Use of fludarabine-containing chemotherapeutic regimen results in durable complete remission of subcutaneous panniculitis-like T-cell lymphoma

American Journal of Clinical Dermatology

Volumn 9, Issue 6, 2008, Pages 396-398

  Chim, Chor Sang ^a   Loong, Florence ^a   Ng, Wai Kuen ^a   Kwong, Yok Lam ^a  

^a QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

Dexamethasone, therapeutic use; Fludarabine, therapeutic use; Mitoxantrone, therapeutic use; T cell lymphoma, treatment

Indexed keywords

ANTHRACYCLINE; DEXAMETHASONE; FLUDARABINE; IMMUNOGLOBULIN HEAVY CHAIN; LACTATE DEHYDROGENASE; MITOXANTRONE; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CLINICAL ASSESSMENT; DISEASE CLASSIFICATION; FEMALE; HEMATOPOIESIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LACTATE DEHYDROGENASE BLOOD LEVEL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RARE DISEASE; SKIN BIOPSY; SUBCUTANEOUS PANNICULITIS LIKE T CELL LYMPHOMA; T CELL LYMPHOMA; WORLD HEALTH ORGANIZATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEXAMETHASONE; FEMALE; HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MITOXANTRONE; PANNICULITIS; SKIN NEOPLASMS; VIDARABINE;

EID: 55249101769     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/0128071-200809060-00007     Document Type: Article

References (14)

1. Jaffe ES, Ralfkiaer E. Subcutaneous panniculitis-like T cell lymphoma. In: Jaffe ES, Harris NL, Stein H, editors. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001: 212-3
2. Go RS, Wester SM. Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis-like T-cell lymphoma: a systematic analysis of 156 patients reported in the literature. Cancer 2004; 101: 1404-13
3. Kwong YL, Wong KF. Association of pure red cell aplasia with T large granular lymphocyte leukaemia. J Clin Pathol 1998; 51: 672-5
4. Au WY, Shek WH, Nicholls J, et al. T-cell intravascular lymphomatosis (angiotropic large cell lymphoma): association with Epstein-Barr viral infection. Histopathology 1997; 31: 563-7
5. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005; 105: 3768-85
6. Craig AJ, Cualing H, Thomas G, et al. Cytophagic histiocytic panniculitis: a syndrome associated with benign and malignant panniculitis: case comparison and review of the literature. J Am Acad Dermatol 1998; 39: 721-36
7. Salhany KE, Macon WR, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998; 22: 881-93
8. Ghobrial IM, Weenig RH, Pittlekow MR, et al. Clinical outcome of patients with subcutaneous panniculitis-like T-cell lymphoma. Leuk Lymphoma 2005; 46: 703-8
9. Tsukamoto Y, Katsunobu Y, Omura Y, et al. Subcutaneous panniculitis-like T-cell lymphoma: successful initial treatment with prednisolone and cyclosporin A. Intern Med 2006; 45: 21-4
10. Elter T, Hallek M, Engert A. Fludarabine in chronic lymphocytic leukaemia. Expert Opin Pharmacother 2006; 7: 1641-51
11. Au WY, Ng WM, Choy C, et al. Aggressive subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine, mitoxantrone and dexamethasone. Br J Dermatol 2000; 143: 408-10
12. Przybylski GK, Wu H, Macon WR, et al. Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes. J Mol Diagn 2000; 2: 11-9
13. Go RS, Gazelka H, Hogan JD, et al. Subcutaneous panniculitis-like T-cell lymphoma: complete remission with fludarabine. Ann Hematol 2003; 82: 247-50
14. Wells J, Kosky CA, Scolyer RA, et al. Unusual case of subcutaneous panniculitis-like T-cell lymphoma. Australas J Dermatol 2004; 45: 114-8